These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 2188479)

  • 1. A double-blind comparison of mianserin and maprotiline in depressed medically ill elderly people.
    Schifano F; Garbin A; Renesto V; De Dominicis MG; Trinciarelli G; Silvestri A; Magni G
    Acta Psychiatr Scand; 1990 Mar; 81(3):289-94. PubMed ID: 2188479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind trial comparing mianserin and maprotiline in depressed inpatients.
    Palha AP; Ferreira L; Abreu-Lima C; Ramalhão C; Fernandes R
    Clin Ther; 1985; 7(5):584-92. PubMed ID: 3902238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placebo-controlled trial of mianserin and maprotiline in primary depressive illness: a preliminary report.
    Edwards JG; Goldie A
    Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):239S-248S. PubMed ID: 6337611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mianserin and maprotiline as compared to amitriptyline in severe endogenous depression. A new methodological approach to the clinical evaluation of the efficacy of antidepressants.
    Cording-Tömmel C; von Zerssen D
    Pharmacopsychiatria; 1982 Nov; 15(6):197-204. PubMed ID: 7156183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A controlled study of the efficacy and safety of mianserin and maprotiline in outpatients with major depression.
    Möller HJ; Riehl T; Dietzfelbinger T; Wernicke T
    Int Clin Psychopharmacol; 1991; 6(3):179-92. PubMed ID: 1806624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic superiority of maprotiline versus doxepin in geriatric depression.
    Gwirtsman HE; Ahles S; Halaris A; DeMet E; Hill MA
    J Clin Psychiatry; 1983 Dec; 44(12):449-53. PubMed ID: 6361005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects on suicidal ideation of mianserin, maprotiline and amitriptyline.
    Montgomery S; Cronholm B; Asberg M; Montgomery DB
    Br J Clin Pharmacol; 1978; 5 Suppl 1(Suppl 1):77S-80S. PubMed ID: 341948
    [No Abstract]   [Full Text] [Related]  

  • 8. Mianserin, maprotiline and intracardiac conduction.
    Edwards JG; Goldie A
    Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):249S-254S. PubMed ID: 6824556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive and psychomotor effects of different antidepressants in the treatment of old age depression.
    Siegfried K; O'Connolly M
    Int Clin Psychopharmacol; 1986 Jul; 1(3):231-43. PubMed ID: 3549874
    [No Abstract]   [Full Text] [Related]  

  • 10. Maprotiline versus imipramine and placebo in neurotic depression.
    van der Velde CD
    J Clin Psychiatry; 1981 Apr; 42(4):138-41. PubMed ID: 7009592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moclobemide compared with second-generation antidepressants in elderly people.
    De Vanna M; Kummer J; Agnoli A; Gentili P; Lorizio A; Anand R
    Acta Psychiatr Scand Suppl; 1990; 360():64-6. PubMed ID: 2248077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to total sleep deprivation before and during treatment with fluvoxamine or maprotiline in patients with major depression--results of a double-blind study.
    Kasper S; Voll G; Vieira A; Kick H
    Pharmacopsychiatry; 1990 May; 23(3):135-42. PubMed ID: 2115680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind study of oxaprotiline versus clomipramine in the treatment of depressive inpatients.
    Wolfersdorf M; Binz U; Wendt G; Metzger R; Hole G
    Neuropsychobiology; 1987; 17(1-2):41-8. PubMed ID: 3306439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CGP 12.103 A versus clomipramine in the treatment of depressed inpatients--results of a double-blind study.
    Wolfersdorf M; Wendt G; Binz U; Steiner B; Hole G
    Pharmacopsychiatry; 1988 Jul; 21(4):203-7. PubMed ID: 3060885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mianserin versus maprotiline in patients with a depressive syndrome.
    Indaco A; Orefice G; Carrieri P
    Acta Neurol (Napoli); 1984 Apr; 6(2):140-6. PubMed ID: 6741655
    [No Abstract]   [Full Text] [Related]  

  • 16. Maprotiline (Ludiomil, Ciba 34,276-BA) and imipramine in depressed outpatients: a double-blind clinical study.
    Singh AN; Saxena B; Gent M; Nelson HL
    Curr Ther Res Clin Exp; 1976 Apr; 19(4):451-62. PubMed ID: 816603
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of depression in outpatients: a controlled comparison of the onset of action of amoxapine and maprotiline.
    Fabre LF
    J Clin Psychiatry; 1985 Dec; 46(12):521-4. PubMed ID: 3905772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoxetine 40 mg vs maprotiline 75 mg in the treatment of out-patients with depressive disorders.
    Poelinger W; Haber H
    Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():47-50. PubMed ID: 2644340
    [No Abstract]   [Full Text] [Related]  

  • 19. A double-blind multicentre trial comparing the efficacy and side-effects of mianserin and chlorimipramine in depressed in- and outpatients.
    Pinder RM; Blum A; Stulemeijer SM; Barres M; Molczadzki M; Rigaud A; Charbaut J; Israel L; Kammerer T
    Int Pharmacopsychiatry; 1980; 15(4):218-27. PubMed ID: 7021447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparisons of maprotiline with imipramine in severe depression: a multicenter controlled trial.
    Logue JN; Sachais BA; Feighner JP
    J Clin Pharmacol; 1979 Jan; 19(1):64-74. PubMed ID: 368087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.